Retatrutide (LY3437943) is a synthetic triple agonist of GLP-1, GIP, and glucagon receptors developed by Eli Lilly, enabling simultaneous modulation of appetite, glycemic control, energy expenditure, and lipid metabolism
Weight yourself under the same conditions and average weekly rather than obsessing over daily fluctuations
Additionally, Melanotan 2 peptide has been studied at length as a potential remedy for the treatment of sexual dysfunction
Common side effects of compounded semaglutide and Wegovy include: Nausea Diarrhea Vomiting Constipation Abdominal pain or discomfort Decreased appetite Indigestion (dyspepsia) Fatigue (general weakness) Dizziness Bloating, gas and gastroesophageal reflux disease (GERD) Less common but more serious side effects can include pancreatitis, gallbladder disease, hypoglycemia in people with type 2 diabetes and kidney problems
19 The therapeutic effects of pioglitazone on MASLD have been well studied 20